ZSAN - Zosano Pharma Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue---313
Cost of Revenue25,50820,11820,45720,366
Gross Profit-25,508-20,118-20,457-20,053
Operating Expenses
Research Development25,50825,50825,50825,508
Selling General and Administrative9,3578,1828,1766,315
Non Recurring----
Others----
Total Operating Expenses34,86528,30028,63326,681
Operating Income or Loss-34,865-28,300-28,633-26,368
Income from Continuing Operations
Total Other Income/Expenses Net-493-805-1,199-2,059
Earnings Before Interest and Taxes-34,865-28,300-28,633-26,368
Interest Expense-379-817-1,192-1,564
Income Before Tax-35,358-29,105-29,832-28,427
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-35,358-29,105-29,832-28,427
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-35,358-29,105-29,832-28,427
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-35,358-29,105-29,832-28,427